Zobrazeno 1 - 7
of 7
pro vyhledávání: '"L. W. Kissell"'
Autor:
Huali Wu, David J. Smith, Lisa A. Tell, Jim E. Riviere, L. W. Kissell, Teresa L. Leavens, Weilin L. Shelver, Sarah A. Wagner, Geoffrey W. Smith, Ronald E. Baynes
Publikováno v:
Food Additives & Contaminants: Part A. 31:1506-1521
Frequent violation of flunixin residues in tissues from cattle has been attributed to non-compliance with the USFDA-approved route of administration and withdrawal time. However, the effect of administration route and physiological differences among
Autor:
Ronette Gehring, Lisa A. Tell, Jim E. Riviere, L. W. Kissell, Patrick D. Brinson, Ronald E. Baynes, Geof W. Smith, S. E. Wetzlich
Publikováno v:
American journal of veterinary research. 77(6)
OBJECTIVE To describe plasma pharmacokinetic parameters and tissue elimination of flunixin in veal calves. ANIMALS 20 unweaned Holstein calves between 3 and 6 weeks old. PROCEDURES Each calf received flunixin (2.2 mg/kg, IV, q 24 h) for 3 days. Blood
Publikováno v:
Journal of Animal Physiology and Animal Nutrition. 97:694-700
Three studies were conducted to determine the potential of experimental feed additives (EFAs), clays or non-digestible yeast oligosaccharides, to reduce milk aflatoxin (AFM1) concentrations in lactating Holstein cows consuming aflatoxin-contaminated
Autor:
Danielle A. Mzyk, Keith D. DeDonder, Tara Marmulak, R. Gehring, Lisa A. Tell, Jennifer Davis, Geof W. Smith, L. W. Kissell, Ronald E. Baynes, Jim E. Riviere
Publikováno v:
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 88
The aim of this manuscript is to review the potential adverse health effects in humans if exposed to residues of selected veterinary drugs used in food-producing animals. Our other objectives are to briefly inform the reader of why many of these drug
Publikováno v:
Journal of the American Veterinary Medical Association. 246(1)
Objective—To determine whether pharmacokinetics and milk elimination of flunixin and 5-hydroxy flunixin differed between healthy and mastitic cows. Design—Prospective controlled clinical trial. Animals—20 lactating Holstein cows. Procedures—C
Publikováno v:
Food additivescontaminants. Part A, Chemistry, analysis, control, exposurerisk assessment. 30(9)
5-Hydroxy-flunixin concentrations in milk samples were quantified by two commercially available screening assays--CHARM® and enzyme-linked immunoabsorbant assay (ELISA)--to determine whether any concentrations could be detected above the tolerance l
Publikováno v:
Journal of dairy science. 95(12)
The objective of this study was to determine if the plasma pharmacokinetics and milk elimination of flunixin (FLU) and 5-hydroxy flunixin (5OH) differ following intramuscular and subcutaneous injection of FLU compared with intravenous injection. Twel